Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?

K. Clarke; M. Taremi; M.R. Dahele; M. Freeman; S.R. Fung; K. Franks; A. Bezjak; A. Brade; J. Cho; A. Hope; A. Sun

doi:10.1016/j.radonc.2012.04.019

Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?

K. Clarke, M. Taremi, M.R. Dahele, M. Freeman, S.R. Fung, K. Franks, A. Bezjak, A. Brade, J. Cho, A. Hope, A. Sun

Radiation Oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	62-66
Journal	Radiotherapy and Oncology
Volume	104
Issue number	1
DOIs	https://doi.org/10.1016/j.radonc.2012.04.019
Publication status	Published - 2012

Access to Document

10.1016/j.radonc.2012.04.019

Cite this

@article{bed0857bf47d43ecb641b0c7e1d2b0c3,

title = "Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?",

author = "K. Clarke and M. Taremi and M.R. Dahele and M. Freeman and S.R. Fung and K. Franks and A. Bezjak and A. Brade and J. Cho and A. Hope and A. Sun",

year = "2012",

doi = "10.1016/j.radonc.2012.04.019",

language = "Undefined/Unknown",

volume = "104",

pages = "62--66",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",